182 related articles for article (PubMed ID: 33205940)
1. Core-Shell Nanosystems for Self-Activated Drug-Gene Combinations against Triple-Negative Breast Cancer.
Liu P; Liu X; Cheng Y; Zhong S; Shi X; Wang S; Liu M; Ding J; Zhou W
ACS Appl Mater Interfaces; 2020 Dec; 12(48):53654-53664. PubMed ID: 33205940
[TBL] [Abstract][Full Text] [Related]
2. Metal organic framework coated MnO
Nie Y; Li D; Peng Y; Wang S; Hu S; Liu M; Ding J; Zhou W
Int J Pharm; 2020 Jul; 585():119513. PubMed ID: 32526334
[TBL] [Abstract][Full Text] [Related]
3. DNAzyme-Loaded Metal-Organic Frameworks (MOFs) for Self-Sufficient Gene Therapy.
Wang H; Chen Y; Wang H; Liu X; Zhou X; Wang F
Angew Chem Int Ed Engl; 2019 May; 58(22):7380-7384. PubMed ID: 30916460
[TBL] [Abstract][Full Text] [Related]
4. A Bimetallic Metal-Organic Framework Encapsulated with DNAzyme for Intracellular Drug Synthesis and Self-Sufficient Gene Therapy.
Wang Z; Niu J; Zhao C; Wang X; Ren J; Qu X
Angew Chem Int Ed Engl; 2021 May; 60(22):12431-12437. PubMed ID: 33739589
[TBL] [Abstract][Full Text] [Related]
5. Silencing of Pyruvate Kinase M2
Huang S; Zhu W; Zhang F; Chen G; Kou X; Yang X; Ouyang G; Shen J
ACS Appl Mater Interfaces; 2021 Dec; 13(48):56972-56987. PubMed ID: 34797638
[TBL] [Abstract][Full Text] [Related]
6. Reversibly-regulated drug release using poly(tannic acid) fabricated nanocarriers for reduced secondary side effects in tumor therapy.
Chen C; Ma T; Tang W; Wang X; Wang Y; Zhuang J; Zhu Y; Wang P
Nanoscale Horiz; 2020 Jun; 5(6):986-998. PubMed ID: 32322871
[TBL] [Abstract][Full Text] [Related]
7. "Triple-punch" strategy for triple negative breast cancer therapy with minimized drug dosage and improved antitumor efficacy.
Su S; Tian Y; Li Y; Ding Y; Ji T; Wu M; Wu Y; Nie G
ACS Nano; 2015 Feb; 9(2):1367-78. PubMed ID: 25611071
[TBL] [Abstract][Full Text] [Related]
8. pH sensitive peptide functionalized nanoparticles for co-delivery of erlotinib and DAPT to restrict the progress of triple negative breast cancer.
Wan X; Liu C; Lin Y; Fu J; Lu G; Lu Z
Drug Deliv; 2019 Dec; 26(1):470-480. PubMed ID: 30957572
[TBL] [Abstract][Full Text] [Related]
9. Biomimetic Nucleation of Metal-Organic Frameworks on Silk Fibroin Nanoparticles for Designing Core-Shell-Structured pH-Responsive Anticancer Drug Carriers.
Chen Y; Wu H; Yang T; Zhou G; Chen Y; Wang J; Mao C; Yang M
ACS Appl Mater Interfaces; 2021 Oct; 13(40):47371-47381. PubMed ID: 34582680
[TBL] [Abstract][Full Text] [Related]
10. Versatile Catalytic Deoxyribozyme Vehicles for Multimodal Imaging-Guided Efficient Gene Regulation and Photothermal Therapy.
Feng J; Xu Z; Liu F; Zhao Y; Yu W; Pan M; Wang F; Liu X
ACS Nano; 2018 Dec; 12(12):12888-12901. PubMed ID: 30540434
[TBL] [Abstract][Full Text] [Related]
11. Self-Assembly of Extracellular Vesicle-like Metal-Organic Framework Nanoparticles for Protection and Intracellular Delivery of Biofunctional Proteins.
Cheng G; Li W; Ha L; Han X; Hao S; Wan Y; Wang Z; Dong F; Zou X; Mao Y; Zheng SY
J Am Chem Soc; 2018 Jun; 140(23):7282-7291. PubMed ID: 29809001
[TBL] [Abstract][Full Text] [Related]
12. A combination of a TLR7/8 agonist and an epigenetic inhibitor suppresses triple-negative breast cancer through triggering anti-tumor immune.
Jiang Z; Cai G; Liu H; Liu L; Huang R; Nie X; Gui R; Li J; Ma J; Cao K; Luo Y
J Nanobiotechnology; 2024 May; 22(1):296. PubMed ID: 38811964
[TBL] [Abstract][Full Text] [Related]
13. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
14. A smart metal-polyphenol-DNAzyme nanoplatform for gene-chemodynamic synergistic tumor therapy.
Xing C; Lin Q; Chen Y; Zeng S; Wang J; Lu C
Acta Biomater; 2023 Sep; 167():564-573. PubMed ID: 37253417
[TBL] [Abstract][Full Text] [Related]
15. In Vivo Targeting and Positron Emission Tomography Imaging of Tumor with Intrinsically Radioactive Metal-Organic Frameworks Nanomaterials.
Chen D; Yang D; Dougherty CA; Lu W; Wu H; He X; Cai T; Van Dort ME; Ross BD; Hong H
ACS Nano; 2017 Apr; 11(4):4315-4327. PubMed ID: 28345871
[TBL] [Abstract][Full Text] [Related]
16. Smart Manganese Dioxide-Based Lanthanide Nanoprobes for Triple-Negative Breast Cancer Precise Gene Synergistic Chemodynamic Therapy.
Ming L; Song L; Xu J; Wang R; Shi J; Chen M; Zhang Y
ACS Appl Mater Interfaces; 2021 Aug; 13(30):35444-35455. PubMed ID: 34292714
[TBL] [Abstract][Full Text] [Related]
17. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
18. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
[TBL] [Abstract][Full Text] [Related]
19. Oxygen Self-Sufficient Core-Shell Metal-Organic Framework-Based Smart Nanoplatform for Enhanced Synergistic Chemotherapy and Photodynamic Therapy.
Ren SZ; Wang B; Zhu XH; Zhu D; Liu M; Li SK; Yang YS; Wang ZC; Zhu HL
ACS Appl Mater Interfaces; 2020 Jun; 12(22):24662-24674. PubMed ID: 32394704
[TBL] [Abstract][Full Text] [Related]
20. Intracellular cascade activated nanosystem for improving ER+ breast cancer therapy through attacking GSH-mediated metabolic vulnerability.
Xiong H; Wang C; Wang Z; Jiang Z; Zhou J; Yao J
J Control Release; 2019 Sep; 309():145-157. PubMed ID: 31348976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
